ScoreComparison
Why is Protalix Biotherapeutics, Inc. ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Protalix Biotherapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.46%
EBIT Growth (5y)
-215.21%
EBIT to Interest (avg)
-0.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
1.14
Tax Ratio
24.19%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
23.59%
ROCE (avg)
58.62%
ROE (avg)
6.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.58
EV to EBIT
-25.97
EV to EBITDA
-35.40
EV to Capital Employed
7.66
EV to Sales
2.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-29.51%
ROE (Latest)
-13.69%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend32What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 15.09 MM
RAW MATERIAL COST(Y)
Fallen by -379.13% (YoY
NET SALES(Q)
Highest at USD 33.75 MM
OPERATING PROFIT(Q)
Highest at USD 21.55 MM
OPERATING PROFIT MARGIN(Q)
Highest at 63.85 %
PRE-TAX PROFIT(Q)
Highest at USD 21.14 MM
NET PROFIT(Q)
Highest at USD 18.32 MM
EPS(Q)
Highest at USD 0.22
-9What is not working for the Company
INTEREST(HY)
At USD 0.58 MM has Grown at 4,700%
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.92 times
Here's what is working for Protalix Biotherapeutics, Inc.
Net Sales
At USD 33.75 MM has Grown at 155.95%
over average net sales of the previous four periods of USD 13.19 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 21.14 MM has Grown at 1,607.92%
over average net sales of the previous four periods of USD -1.4 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 18.32 MM has Grown at 1,209.45%
over average net sales of the previous four periods of USD -1.65 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 15.09 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 33.75 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 21.55 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 63.85 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 21.14 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 18.32 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.22
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -379.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Protalix Biotherapeutics, Inc.
Interest
At USD 0.58 MM has Grown at 4,700%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 0.92 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
